Alnylam Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
246
697
1,081
627
1,691
1,084
Total Accounts Receivable
4
40
8
23
34
19
Other Current Assets
4
10
17
22
40
73
Total Current Assets
254
746
1,105
672
1,765
1,201
Net Property, Plant & Equipment
16
22
28
115
182
321
Total Investments and Advances
150
280
253
476
45
47
Total Assets
421
1,080
1,387
1,263
1,995
1,575
Accounts Payable
6
15
17
54
28
Income Tax Payable
-
32
-
-
-
Other Current Liabilities
48
49
45
77
116
Total Current Liabilities
54
95
62
132
144
Long-Term Debt
-
-
-
150
30
Deferred Taxes
-
32
-
-
-
Other Liabilities
96
48
60
61
54
Total Liabilities
150
143
122
343
228
Common Equity (Total)
270
936
1,265
920
1,766
Total Shareholders' Equity
270
936
1,265
920
1,766
Total Equity
270
936
1,265
920
1,766
Liabilities & Shareholders' Equity
421
1,080
1,387
1,263
1,995
About Alnylam Pharmaceuticals
View Profile
